See more : Oriental Aromatics Limited (OAL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Gladstone Commercial Corporation (GOOD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gladstone Commercial Corporation, a leading company in the REIT – Diversified industry within the Real Estate sector.
- Alpha Wastewater, Inc. (AWWI) Income Statement Analysis – Financial Results
- Agfa-Gevaert NV (AGFB.BR) Income Statement Analysis – Financial Results
- ARC Resources Ltd. (ARX.TO) Income Statement Analysis – Financial Results
- Radius Health, Inc. (RDUS) Income Statement Analysis – Financial Results
- TROC DE L’ILE SA (MLTRO.PA) Income Statement Analysis – Financial Results
Gladstone Commercial Corporation (GOOD)
About Gladstone Commercial Corporation
Gladstone Commercial Corporation is a real estate investment trust focused on acquiring, owning, and operating net leased industrial and office properties across the United States. Including payments through September 2020, Gladstone Commercial has paid 189 consecutive monthly cash distributions on its common stock. Prior to paying distributions on a monthly basis, Gladstone Commercial paid five consecutive quarterly cash distributions. The company has also paid 53 consecutive monthly cash distributions on its Series D Preferred Stock, 12 consecutive monthly cash distributions on its Series E Preferred Stock and three consecutive monthly cash distributions on its Series F Preferred Stock. Gladstone Commercial has never skipped, reduced or deferred a distribution since its inception in 2003.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 147.58M | 148.98M | 137.69M | 133.15M | 114.39M | 106.80M | 94.80M | 86.37M | 83.77M | 73.76M | 61.34M | 51.27M | 43.98M | 41.93M | 42.61M | 40.91M | 32.79M | 25.95M | 13.47M | 4.31M | 316.28K |
Cost of Revenue | 32.24M | 26.83M | 27.10M | 26.00M | 12.59M | 11.46M | 7.69M | 5.89M | 5.30M | 4.71M | 3.35M | 1.59M | 986.00K | 971.47K | 915.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 115.35M | 122.15M | 110.59M | 107.15M | 101.80M | 95.34M | 87.11M | 80.48M | 78.47M | 69.05M | 58.00M | 49.68M | 42.99M | 40.96M | 41.69M | 40.91M | 32.79M | 25.95M | 13.47M | 4.31M | 316.28K |
Gross Profit Ratio | 78.16% | 81.99% | 80.32% | 80.47% | 88.99% | 89.27% | 91.89% | 93.18% | 93.68% | 93.61% | 94.54% | 96.90% | 97.76% | 97.68% | 97.85% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.07 | 0.07 | 0.11 | 0.08 | 0.12 | 0.06 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 6.71M | 17.17M | 15.41M | 14.81M | 13.79M | 12.06M | 11.02M | 9.91M | 9.14M | 8.16M | 5.88M | 6.48M | 2.52M | 9.56M | 7.05M | 8.75M | 1.57M | 469.26K | 466.87K | 442.23K | 47.72K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 6.71M | 17.17M | 15.41M | 14.81M | 13.79M | 12.06M | 11.02M | 9.91M | 9.14M | 8.16M | 5.88M | 6.48M | 8.25M | 9.56M | 7.05M | 8.75M | 1.57M | 469.26K | 466.87K | 442.23K | 47.72K |
Other Expenses | 0.00 | 61.66M | 60.31M | 55.42M | 52.04M | 72.00K | 52.00K | -1.16M | -2.73M | -2.57M | -2.64M | -2.39M | 12.04M | 12.88M | 12.58M | 10.64M | 14.26M | 13.60M | 6.88M | 2.86M | 509.43K |
Operating Expenses | 73.09M | 78.83M | 75.72M | 70.23M | 65.83M | 59.68M | 53.81M | 47.43M | 44.43M | 37.02M | 28.71M | 23.31M | 20.28M | 22.44M | 19.63M | 19.39M | 15.82M | 14.07M | 7.35M | 3.30M | 557.15K |
Cost & Expenses | 96.81M | 105.67M | 102.82M | 96.23M | 78.42M | 71.14M | 61.50M | 53.32M | 49.72M | 41.73M | 32.06M | 24.90M | 21.27M | 23.41M | 20.54M | 19.39M | 15.82M | 14.07M | 7.35M | 3.30M | 557.15K |
Interest Income | 0.00 | 32.46M | 26.89M | 26.80M | 28.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.00K | 579.75K | 213.10K | 223.94K | 354.25K | 0.00 | 0.00 | 614.66K | 0.00 |
Interest Expense | 37.33M | 32.46M | 26.89M | 26.80M | 28.28M | 26.17M | 24.57M | 25.90M | 28.01M | 26.20M | 24.35M | 20.23M | 17.08M | 17.06M | 17.89M | 16.86M | 11.56M | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 57.86M | 104.16M | 102.80M | 96.23M | 78.38M | 71.12M | 61.50M | 40.16M | 35.29M | 28.86M | 22.83M | 16.83M | 14.15M | 13.26M | 13.17M | 13.99M | 10.53M | 8.35M | 4.30M | 973.35K | 5.83K |
EBITDA | 101.30M | 100.86M | 96.97M | 90.51M | 88.72M | 83.28M | 42.80M | 37.52M | 35.29M | 28.86M | 48.71M | 16.83M | 19.86M | 28.46M | 35.24M | 17.65M | 27.50M | 20.18M | 10.42M | 1.98M | -235.04K |
EBITDA Ratio | 68.64% | 70.79% | 71.25% | 69.69% | 77.56% | 78.05% | 80.32% | 80.36% | 79.51% | 79.07% | 80.65% | 79.61% | 83.70% | 67.88% | 82.68% | 86.64% | 83.71% | 76.49% | 77.40% | 45.97% | -74.32% |
Operating Income | 50.78M | 43.77M | 37.75M | 37.31M | 36.68M | 35.66M | 33.30M | 33.05M | 34.05M | 32.03M | 29.29M | 26.38M | 5.67M | 18.51M | 4.39M | 21.52M | 16.97M | 11.88M | 6.12M | 1.01M | -544.97K |
Operating Income Ratio | 34.41% | 29.38% | 27.42% | 28.02% | 32.07% | 33.39% | 35.12% | 38.27% | 40.64% | 43.42% | 47.74% | 51.44% | 12.88% | 44.16% | 10.30% | 52.60% | 51.75% | 45.78% | 45.45% | 23.40% | -172.31% |
Total Other Income/Expenses | -45.86M | -34.04M | -25.16M | -21.93M | -26.43M | -23.34M | -27.36M | -28.84M | -29.83M | -37.93M | -26.99M | -23.56M | -17.69M | -13.59M | -4.39M | -21.44M | -10.94M | -8.52M | -2.19M | 614.66K | 544.97K |
Income Before Tax | 4.92M | 9.27M | 9.73M | 14.99M | 9.54M | 12.32M | 5.94M | 3.96M | 3.60M | -5.90M | 1.53M | 3.76M | 150.00 | 0.09 | 0.04 | 0.10 | 0.23 | 0.14 | 3.60M | 1.62M | 0.00 |
Income Before Tax Ratio | 3.34% | 6.22% | 7.07% | 11.25% | 8.34% | 11.54% | 6.26% | 4.58% | 4.29% | -8.00% | 2.49% | 7.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 26.75% | 37.66% | 0.00% |
Income Tax Expense | 0.00 | 32.46M | 29.73M | 27.25M | 28.90M | 2.84M | 24.62M | 24.74M | 25.29M | 23.63M | 21.71M | 17.84M | 16.99M | 13.59M | 17.47M | 16.61M | 10.83M | 7.51M | 0.00 | 0.00 | 0.00 |
Net Income | 4.99M | -23.19M | -19.99M | -12.26M | -19.36M | 12.32M | 5.94M | 3.96M | 3.60M | -5.90M | 1.53M | 3.76M | 5.71M | 4.93M | 4.60M | 4.91M | 6.14M | 4.37M | 3.60M | 1.62M | -240.87K |
Net Income Ratio | 3.38% | -15.56% | -14.52% | -9.21% | -16.93% | 11.54% | 6.26% | 4.58% | 4.29% | -8.00% | 2.49% | 7.34% | 12.99% | 11.75% | 10.80% | 12.01% | 18.72% | 16.85% | 26.75% | 37.66% | -76.16% |
EPS | -0.19 | -0.59 | -0.54 | -0.35 | -0.62 | 0.43 | -0.19 | -0.16 | -0.07 | -0.34 | -0.22 | -0.04 | 0.15 | 0.09 | 0.06 | 0.10 | 0.24 | 0.28 | 0.47 | 0.21 | -0.17 |
EPS Diluted | -0.19 | -0.59 | -0.54 | -0.35 | -0.62 | 0.43 | -0.19 | -0.16 | -0.07 | -0.33 | -0.22 | -0.04 | 0.15 | 0.09 | 0.06 | 0.10 | 0.24 | 0.27 | 0.47 | 0.21 | -0.17 |
Weighted Avg Shares Out | 40.23M | 39.26M | 37.00M | 34.58M | 31.29M | 28.68M | 25.99M | 23.87M | 21.83M | 17.25M | 13.03M | 10.95M | 10.24M | 8.58M | 8.56M | 8.57M | 8.57M | 7.83M | 7.67M | 7.65M | 1.45M |
Weighted Avg Shares Out (Dil) | 39.94M | 39.26M | 37.00M | 34.58M | 31.29M | 28.68M | 26.36M | 24.15M | 22.12M | 17.77M | 13.45M | 11.06M | 10.29M | 8.60M | 8.56M | 8.57M | 8.57M | 7.99M | 7.72M | 7.71M | 1.45M |
Gladstone Commercial Corporation Announces Election of Katharine Cornell Gorka as Director
Gladstone Commercial (GOOD) Renews Lease With Morgan Stanley
Gladstone Commercial Executes 5 Year Lease Renewal at Office Property in Columbus, OH
Gladstone Commercial Series E Preferred: We're Still Glad
Gladstone Commercial: 8% Yield, 83% Pay-Out Ratio, Strategic Portfolio Shift
Gladstone Commercial Series G Preferred: Solid 7.5% Monthly Payer With 25% Upside To Call
Gladstone Commercial (GOOD) Sells Georgia Medical Office Assets
Stonegate Capital Partners Updates 2Q24 Report on Gladstone Commercial Corp. (GOOD)
Gladstone Commercial Corporation Announces Sale of Georgia Medical Office Portfolio
Gladstone Commercial Corporation (GOOD) Q2 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports